
Andrew Welch, DO
Assistant Professor of Clinical
Medical Sciences Building
COM IM Endocrinology Division - 0547
Education
BS: Brigham Young University Provo, UT, 2013 (Neuroscience)
DO: Arizona College of Osteopathic Medicine Glendale, AZ, 2020
Certifications
American Board of Internal Medicine (Endocrinology-Diabetes and Metabolism) (Certification Date: 10-24-2023 )
American Board of Internal Medicine (Certification Date: 08-20-2020 )
Clinical Interests
Diabetes
Endocrinology
Thyroid Cancer
Adrenal Insufficiency
Adrenocortical Adenoma
Cushing syndrome (Hypercortisolism)
Diabetes Mellitus
Diabetes Type 1 (Diabetes Mellitus, Type 1)
Diabetes Type 2 (Diabetes Mellitus, Type 2)
Diabetic Foot
Diabetic Hypoglycemia
Diabetic Ketoacidosis
Diabetic Nephropathy
Diabetic Neuropathies
Hyperparathyroidism
Hyperthyroidism
Hypothyroidism (Underactive thyroid)
Obesity
Osteoporosis
Pituitary Adenoma
Prolactinoma
Specialities
Endocrinology-Diabetes and Metabolism
Internal Medicine
Research Support
Grant: #10769-UC / 3-SRA-2025-1787-M-B Investigators:Welch, Andrew 09-01-2025 -08-31-2028 Breakthrough T1D Safety and Efficacy of Adjunct Therapies in Adults with Type 1 diabetes: Multicenter, Registry-based Study Role:PI 11660.00 Hold Level:Non Profit
Publications
Peer Reviewed Publications
Welch, Andrew A; Farahani, Rahele A; Egan, Aoife M; Laurenti, Marcello C; Zeini, Maya; Vella, Max; Bailey, Kent R; Cobelli, Claudio; Dalla Man, Chiara Dalla; Matveyenko, Aleksey; Vella, Adrian (2023). The effect of Glucagon-Like Peptide-1 Receptor blockade on islet secretion and glucose metabolism in humans. The Journal of clinical investigationMore Information
Schembri Wismayer, Daniel; Laurenti, Marcello C; Song, Yilin; Egan, Aoife M; Welch, Andrew A; Bailey, Kent R; Cobelli, Claudio; Dalla Man, Chiara; Jensen, Michael D; Vella, Adrian (2023). Effects of acute changes in fasting glucose and free fatty acid concentrations on indices of β-cell function and glucose metabolism in subjects without diabetes. American journal of physiology. Endocrinology and metabolism, 325 (2) , E119-E131More Information
Farahani, Rahele A; Egan, Aoife M; Welch, Andrew A; Laurenti, Marcello C; Cobelli, Claudio; Dalla Man, Chiara; Vella, Adrian (2023). The Effect of Glucagon-Like Peptide 1 Receptor Blockade on Glucagon-Induced Stimulation of Insulin Secretion. Diabetes, 72 (4) , 449-454More Information
Brar, Gurkirat S; Barrow, Breanne M; Watson, Matthew; Griesbach, Ryan; Choung, Edwina; Welch, Andrew; Ruzsicska, Bela; Raleigh, Daniel P; Zraika, Sakeneh (2017). Neprilysin Is Required for Angiotensin-(1-7)'s Ability to Enhance Insulin Secretion via Its Proteolytic Activity to Generate Angiotensin-(1-2). Diabetes, 66 (8) , 2201-2212More Information
Welch, Andrew A; Toro-Tobon, David; Rachmasari, Kharisa N; Sandooja, Rashi B; Rahimi, Leili; Mohan, Sneha; Hewlett, Jennifer R; Clark, Jennifer; Maheshwari, Arvind; Zhang, Catherine; Brito, Juan P (2024). Improving Intravenous and Subcutaneous Insulin Overlap During Treatment of Diabetic Ketoacidosis: A Quality Improvement Project. Mayo Clinic proceedings. Innovations, quality & outcomes, 8 (3) , 293-300More Information